A detailed history of Haven Capital Group, Inc. transactions in Incyte Corp stock. As of the latest transaction made, Haven Capital Group, Inc. holds 20,142 shares of INCY stock, worth $1.38 Million. This represents 1.31% of its overall portfolio holdings.

Number of Shares
20,142
Holding current value
$1.38 Million
% of portfolio
1.31%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 10, 2025

BUY
$65.08 - $83.38 $1.31 Million - $1.68 Million
20,142 New
20,142 $1.39 Billion

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $15.2B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Haven Capital Group, Inc. Portfolio

Follow Haven Capital Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Haven Capital Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Haven Capital Group, Inc. with notifications on news.